Organization
OneCell Dx
11 abstracts
Abstract
Association of complementing circulating tumor DNA and circulating tumor cells load on stable and progressive disease in treated patients.Org: OneCell Dx, Mumbai Oncocare Centre, MOC Cancer Care & Research Centre, Omega Hospital, HCG Cancer Care,
Abstract
Therapeutic potential of immune-cold solid tumors through homologous recombination deficiency.Org: OneCell Dx Inc., OneCell Dx, Indx Technology, OneCell Diagnostics,
Abstract
Comparative genomic profiling of circulating tumor DNA and paired formalin-fixed paraffin-embedded (FFPE) DNA from Indian patients with breast cancer.Org: OneCell Dx, Indx Technology, OneCell Dx Inc., Apollo Speciality Hospital,
Abstract
Identification of SNVs via targeted comprehensive genome profiling in patients with brain cancer.Org: One Cell Dx, School of Consciousness Studies, MIT-WPU, Pune, India, Dr. D.Y. Patil Vidyapeeth, OneCell Dx,
Abstract
Identification of novel actionable SNVs using targeted comprehensive genome profiling in patients with sarcoma.Org: OneCell Dx, Pune, Indiana University – Purdue University Indianapolis, Indx Technology, Cupertino, CA,
Abstract
Comprehensive ctDNA analysis to identify genome-instability and actionable mutation landscape in gynecologic cancers.Org: OneCell Dx, Indx Technology, Bhaktivedanta Hospital And Research Centre and School of Consciouness, MIT WPU, De Dy Patil Medical College & Research Centre,
Abstract
Identification of novel actionable SNVs via targeted comprehensive genome profiling in patients with gallbladder and cholangiocarcinoma cancer.Org: Bhaktivedanta Hospital And Research Centre and School of Consciouness, MIT WPU, OneCell Dx, Indx Technology, Artemis Hospital Gurgaon,
Abstract
Effect of circulating tumor cells distribution in treatment naive and treated patients with advance stage breast cancer on disease burden.Org: Actorius Innovations and Research Co, Bhaktivedanta Hospital And Research Centre and School of Consciouness, MIT WPU, Actorius Innovations and Research Pvt. Ltd., Actorius Innovation and Research,
Abstract
Comprehensive plasma genotyping reveals mutational signatures that confer resistance to tyrosine kinase inhibitors (TKI) in patients with advanced lung cancer.Org: OneCell Dx, Tata Memorial Hospital (HBNI), OneCell Diagnostics, School of Consciousness, MIT WPU, Indx Technology,
Abstract
Mutational profiling of true single circulating tumor cells (sCTC) in metastatic lung cancer to determine genomic heterogeneity and drug-resistance signatures.Org: OneCell Diagnostics, Cupertino, CA, OneCell Dx, Pune, Tata Memorial Hospital (HBNI),
Abstract
Comprehensive plasma genotyping of patients with EGFR positive NSCLC as a monitoring tool for therapy response and disease progression.Org: One Cell Dx, Tata Memorial Hospital (HBNI), OneCell Dx, Tata Memorial Centre, Indx Technology,